The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Jun 2007 12:18

ReGen Therapeutics PLC21 June 2007 21 June 2007 REGEN THERAPEUTICS PLC ("ReGen" or the "Company"; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): ReGen Therapeutics Plc 2. Reason for the notification: An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation (iii): Barclays PLC 4. Full name of shareholder(s) (if difference from 3): Barclays Stockbrokers Ltd Gerrard Investment Management Ltd 5. Date of the transaction and date on which the threshold is crossed or reached (v): 19 June 2007 6. Date on which issued notified: 20 June 2007 7. Threshold(s) that is/are crossed or reached: 5% to 4% 8. Notified details A: Voting rights attached to shares Class/type of share if possible using the ISIN Code GB0004468319 Situation Previous to the triggering transaction (vi) - Number of Shares 48,753,387 Number of Voting Rights (viii) 48,753,387 Resulting situation after the triggering transaction (viii) - Number of Shares 50,811,919 Number of Voting Rights - Direct (x) N/A Number of Voting Rights - Indirect (xi) 50,811,919 % of voting rights - Direct N/A % of voting rights - Indirect 4.95 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of financial instrument N/A Expiration date (xiii) N/A Exercise/Conversion Period/Date (xiv) N/A Number of voting rights that may be acquired if theinstrument is exercised/converted N/A % of voting rights N/A Total (A+B) Number of voting rights 50,811,919 % of voting rights 4.95 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Barclays Stockbrokers LtdGerrard Investment Management Ltd Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: N/A 15. Contact telephone number: N/A For further information: Andrew MarshallGreycoat CommunicationsTel: +44 (0) 207 960 6007Mobile: +44 (0) 7785 297111 Rory Creedon/ Cecil JordaanHB-CorporateTel: +44(0) 207 510 8600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jul 20083:25 pmRNSSubstantial Shareholding
30th Jul 20089:51 amRNSUpdate on ADRs - Replacement
29th Jul 20081:47 pmRNSUpdate on ADRs
14th Jul 20082:30 pmRNSADRs listed on International
11th Jul 200810:51 amRNSSubstantial Shareholding
9th Jul 20084:16 pmRNSBoard Changes
26th Jun 200810:00 amRNSNew Study published
19th Jun 20085:26 pmRNSSubstantial Shareholding
17th Jun 200812:03 pmRNSResults of Zolpidem study
10th Jun 200810:12 amRNSSales Update
3rd Jun 200812:44 pmRNSResult of AGM
3rd Jun 200811:00 amRNSAGM Statement
16th May 20082:44 pmRNSShareholding
14th May 200811:23 amRNSHealthcare Conference
30th Apr 20089:13 amRNSTotal Voting Rights
28th Apr 200812:28 pmRNSAnnual Report and Accounts
25th Apr 20081:35 pmRNSScientific Review published
21st Apr 20085:43 pmRNSShareholding
17th Apr 20087:00 amRNSIssue of Equity
7th Apr 200812:14 pmRNSSubstantial Shareholding
2nd Apr 20089:00 amRNSPreliminary Results
1st Apr 20083:33 pmRNSHolding(s) in Company
31st Mar 20089:10 amRNSTotal Voting Rights
31st Mar 20088:00 amRNSResults of Study
28th Mar 20089:00 amRNSFurther Placing
26th Mar 20089:00 amRNSNew Broker and Placing
25th Mar 20083:12 pmRNSEU Import & Sale Approved
18th Mar 20089:00 amRNSChange of Registered Address
10th Mar 20087:00 amRNSEU Distributor Appointed
12th Feb 20085:59 pmRNSShareholding
11th Feb 20087:00 amRNSColostrinin Study Results
31st Jan 20083:00 pmRNSShareholding
2nd Jan 20084:53 pmRNSMajor Interest in Shares
10th Dec 20074:30 pmRNSResearch Update
6th Dec 20075:43 pmRNSSignificant Shareholding
5th Dec 20071:13 pmRNSHolding(s) in Company
5th Dec 20071:08 pmRNSHolding(s) in Company
4th Dec 200711:39 amRNSHolding(s) in Company
30th Nov 200711:30 amRNSTotal Voting Rights
22nd Nov 200711:34 amRNSHolding(s) in Company
21st Nov 20072:01 pmRNSDirector/PDMR Shareholding
20th Nov 20074:45 pmRNSResult of EGM
20th Nov 200712:08 pmRNSEGM Statement
14th Nov 20079:02 amRNSHolding(s) in Company
9th Nov 20074:06 pmRNSHolding(s) in Company
8th Nov 20075:22 pmRNSHolding(s) in Company
2nd Nov 20073:24 pmRNSHolding(s) in Company
31st Oct 20079:00 amRNSZolpidem on BBC 1 documentary
29th Oct 20077:01 amRNSHolding(s) in Company
26th Oct 20073:58 pmRNSCapital Consolidation, EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.